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Innate Immunology of Bovine Respiratory Disease
Abstract
Pneumonia is a leading cause of loss to the cattle industry in the United States and Europe. Of cattle diseases,
it has the greatest economic impact. Respiratory pathogens can cause serious outbreaks of acute pneumonia in
neonatal, weaned and growing calves. Chronic infection leads to debilitation, decreased performance, and
culling in older animals. The means to enhance effective and non-injurious immune responses are needed
because of the high incidence of pneumonia in cattle, ubiquity of respiratory pathogens, the increasing
frequency of antibiotic resistance, and the general expectation by consumers for producers to use antibiotics
less frequently. The lung has a wide array of both innate and adaptive immune responses to airborne
particulates, vapors, and microbial pathogens. Vaccines can effectively enhance resistance to some pathogens,
but not all. More recently, additional attention has been given to innate immune responses and method/
regimens that increase innate immune activity. Despite advances in managerial practices, vaccines, and clinical
therapies, pneumonia remains a widespread problem and methods to enhance host resistance to pathogen
colonization and pneumonia are needed.
There are a variety of factors and conditions that pre-dispose cattle to pneumonia. Cattle have anatomic and
cellular differences from humans and other species and are managed in groups/ herds all of which increases
susceptibility to microbial pathogens. This review highlights the basic innate immune response of the
respiratory tract and newer developments in the understanding of adaptive immune responses of the bovine
respiratory tract placing special emphasis on features unique to cattle.
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INTRODUCTION
Pneumonia is a leading cause of loss to the cattle industry in the United States and Europe. Of
cattle diseases, it has the greatest economic impact. Respiratory pathogens can cause serious
outbreaks of acute pneumonia in neonatal, weaned and growing calves. Chronic infection leads
to debilitation, decreased performance, and culling in older animals. The means to enhance
effective and non-injurious immune responses are needed because of the high incidence of
pneumonia in cattle, ubiquity of respiratory pathogens, the increasing frequency of antibiotic
resistance, and the general expectation by consumers for producers to use antibiotics less
frequently. The lung has a wide array of both innate and adaptive immune responses to airborne
particulates, vapors, and microbial pathogens. Vaccines can effectively enhance resistance to
some pathogens, but not all. More recently, additional attention has been given to innate
immune responses and method/regimens that increase innate immune activity. Despite
advances in managerial practices, vaccines, and clinical therapies, pneumonia remains a
widespread problem and methods to enhance host resistance to pathogen colonization and
pneumonia are needed.
There are a variety of factors and conditions that pre-dispose cattle to pneumonia. Cattle have
anatomic and cellular differences from humans and other species and are managed in groups/
herds all of which increases susceptibility to microbial pathogens. This review highlights the
basic innate immune response of the respiratory tract and newer developments in the
understanding of adaptive immune responses of the bovine respiratory tract placing special
emphasis on features unique to cattle.
© 2009 Elsevier Inc. All rights reserved.
Correspondence to: Mark R Ackermann.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Vet Clin North Am Food Anim Pract. Author manuscript; available in PMC 2011 July 1.
Published in final edited form as:















The upper respiratory tract is colonized by a variety of bacterial pathogens that are inhaled and/
or replicate in the tonsillar crypts and nasal/sinus mucin. Colonization of these organisms
within regions of the upper respiratory tract mucosa may occupy micronutrients and receptor
sites resulting in reduced colonization by pathogens. In a study from 1964, bacterial isolates
from trachea and lung were colonized by Bacillus sp., Streptococcus sp. Streptomyces sp.
Micrococcus sp., and Pseudomonas sp (1). A 1991 study demonstrated Pasteurella
(Mannheima) haemolytica, Pasteurella multocida, Mycoplasma bovine, and M. Bovirhinis,
Histophilus somni, Streptomycetes sp., Neisseria spp. and Bacillus spp. in nasopharyngeal
swabs of healthy calves (2). The deeper lung remains relatively sterile in healthy cattle;
however, in a recent study of bronchoalveolar lavage fluid from cattle in Denmark (3), 63%
of healthy cattle harbored bovine bacterial pathogens (Pasteurella multocida, Histophilus
somni, Mannheimia haemolytica, Arcanobacterium pyogenes, and Mycoplasma sp.).
Pathogenic microflora
Bovine respiratory disease complex (BRDC) is a complex infectious disease caused by the
interaction of several microbial agents. These include viruses that have a tendency to infect
immunocompromised lung: bovine herpesvirus-1 (BHV-1); bovine respiratory syncytial virus,
bovine parainfluenza virus 3, bovine coronavirus, bovine adenovirus A–D, and bovine viral
diarrhea virus 1 and 2. Many herds of cattle are colonized by Mycoplasma spp. (bovis, dispar,
bovirhinis) which inhibition function and activity of ciliated respiratory epithelial cells. Initial
viral infections, toxins such as 3-methyl indole, or other immunosuppressive conditions allow
increased replication of other bacterial pathogens: Mannheimia haemolytica, Pasteurella
multocida, Histophilus somni, Arcanobacterium pyogenes, and Chlamydiaceae. Mannheimia,
Pasteurella and Histophilus can colonize the tonsil and mucous of the nasal meatus and sinuses.
With stress, their replication increases and their area of colonization spreads.
Respiratory airways
Cattle have a relatively long tracheobronchial tree which increases the amount of dead space
volume in comparison to dogs, pigs and horses (4). Increased dead space affects the amount
of fresh oxygen that can be delivered to lung and increases the risk of alveolar hypoventilation
with partial obstruction. The increased dead space in cattle may not affect respiratory tract
immunity per se; however, it may allow increased surface area for particulate deposition and
increased transit time of inhaled vapors, gases and particulate matter.
Hairs
Hairs along the external nares provide a physical barrier to inhalation of large particulate matter.
Squamous cells that line the anterior nares form a layer of stratified squamous epithelium which
is more resistant to microbial adhesion compared to pseudostratified epithelium.
Mucociliary apparatus
The air-surface liquid (ASL) lining the upper respiratory tract and pulmonary airways is
generated largely from submucosal glands and goblet cells and provides a layer of protection
against inhaled particulate matter, aerosols, vapors, and microbial pathogens (Fig. 1). The
antimicrobial activity of the ASL is becoming increasingly understood. The ASL has two
layers, a periciliary sol layer close to the apical cell surface and a gel/mucus layer that is toward
the airway lumen. Ciliary beat occurs principally within the sol layer which is less viscous than
the gel layer. Dehydration can enhance the viscosity of the ASL as can aggregates of DNA and
filamentous actin that accumulate from degraded neutrophils, leukocytes, and necrotic
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epithelial cells along with bacterial biofilms. Sneezing and coughing help to expel particulates
and ASL/mucin aggregates and also induces some dilation of the airway lumens.
Air surface liquid (ASL)
Once considered simply a lubricant for airway function, the ASL has a very active role in innate
defense. Water accumulates within the periciliary sol layer after secretion of chloride ions by
epithelial cells, submucosal glands and serous cells and water is resorbed as sodium is removed
from the layer by epithelial Na+ channels (ENaC). In addition to providing a microenvironment
for ciliary activity, the periciliary sol layer maintains a proper pH (slightly more acidic than
blood). The gel layer of the ASL is composed of mucin glycoproteins and proteoglycans
secreted by goblet cells and submucosal glands. The amount of this layer can increase with
chronic inflammatory conditions, allergic conditions, and cholinergic stimulation. The mucin
glycoproteins are either tethered to the apical membrane of the subjacent epithelial cell or
secreted. The protein backbone of the mucin glycoproteins encoded by MUC genes contain
repeating serine and threonine amino acids that form O-linkages with oligosaccharides. In
humans, MUC1 and MUC4 (and also MUC 11, 13, 15 and 20) proteins are associated with the
apical surface whereas MUC5AC is secreted from goblet cells and MUC5B is secreted from
mucous cells of submucosal glands (5). Variations of MUC gene expression change with
inflammation and lung injury. MUC proteins serve as receptors and signaling molecules and
can bind bacteria. For example, MUC1 is a receptor for Pseudomonas aeruginosa flagellin
protein, activate Src tyrosine kinases and activate phospholipase C and protein kinase C. MUC7
is a non-gel forming secreted mucin.
The ASL contains numerous molecules that mediate antimicrobial as well as pro- and anti-
inflammatory activity, immunomodulation, and wound healing (6). The osmotic gradient is
maintained by sodium and chloride level levels regulated by sodium and chloride transport
pumps and channels which allows proper protein, enzyme, and peptide activity. The presence
and activity of some of these, such as lactoferrin and lysozyme have been known for many
years. Lactoferrin binds and sequesters iron from microbial agents, whereas lysozyme can
disrupt membranes of bacteria. Additional components of the ASL have been indentified in
cattle and other species and increasingly appreciated for the immune and immunomodulatory
role. These include antimicrobial peptides such as defensins, cathelicidins, and larger proteins
(7). There are three major subclassifications of defensins and two, the alpha and beta defensins
are present in cattle.
Three beta-defensins of cattle include tracheal antimicrobial peptide (TAP), lingual
antimicrobial peptide (LAP) and enteric antimicrobial peptide. TAP and LAP are produced by
respiratory epithelia and TAP has the highest level of expression. In fact, TAP was the first
mammalian defensin identified being isolated and cloned by Gill Diamond in 1991 (8). Both
TAP, LAP and other defensins can form pores in the membranes of bacteria, enveloped viruses,
and other microbial agents resulting in rapid lysis. Beta defensins have numerous other
activities that range from exacerbating the acute inflammatory reaction by triggering histamine
release from mast cells, to triggering the adaptive immune response through their chemotactic
properties to dendritic cells, to inducing wound healing via their mitogenic function in epithelial
cells. Cercropin is an antimicrobial peptide from insects that, when delivered by vector to
bovine mucosa, reduces colonization by Mannheimia haemoyltica (9). Bovine neutrophils have
numerous alpha defensins as well; however, these are produced in neutrophils and are present
in the ASL only after neutrophils recruitment and degranulation. Cathelicidin antimicrobial
peptides are also produced in neutrophils and can be released by lung epithelia; however,
epithelial expression is apparently low and limited. Airway epithelial cells also produce
RNAase 7 an RNA helicase with antimicrobial properties; however, the expression levels of
RNAase in cattle is not known. Bovine neutrophils express 13 alpha defensins that are released
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upon degranulation and contribute to microbial killing and the acute inflammatory reaction.
Binding of defensins and other antimicrobial peptides to host membranes is limited
presumeably due to the higher cholesterol content of mammalian cells and thus, autotoxicity
by these peptides is not a feature of the their activity.
In alveoli of deep lung, alveolar macrophages engulf particulate matter and pathogens that
manage to be inhaled into the deep lung. Once activated, the macrophages release cytokines,
chemokines, and other soluble mediators that stimulate an inflammatory and/or immune
response. Cells lining alveoli (type I pneumocytes) are covered by a layer of surfactant,
composed of phosphatidylcholine and other phospholipids which prevents alveolar collapse
by its effect on apical membrane surface tension. Surfactant is secreted by airway type II cells
and Clara cells along with surfactant proteins. Intracellularly, surfactant proteins B and C are
associated with surfactant and maintain surfactant folding/structure until release. Surfactant
proteins A and D are also associated with surfactant and released by psuedostratified ciliated
cells, type II and Clara cells into the airway and/or alveolar lumen and have very potent
antimicrobial and immunomodulatory roles. Surfactant protein A (SP-A) and D (SP-D) can
bind and inactivate microbial agents. Both of these proteins have a carbohydrate recognition
domain (CRD) that binds to mannose residues of microbial pathogens. Once bound, the
pathogen and surfactant protein complex can aggregate and be taken up by alveolar
macrophages. This is well documented for respiratory syncytial virus (RSV) in humans (6) and
individuals altered surfactant proteins A and/or D due to nucleotide polymorphisms have
increased numbers of RSV infection and increased severity. Once released, SP-A can activate
macrophages and enhance macrophage uptake and killing of microbial pathogens. In addition,
SP-A present within the alveolar lumen liquid can be taken up by the pulmonary lymphatic
drainage system and enter the blood. Increased levels of SP-A in blood is associated with
pneumonia and could be a useful biomarker of pneumonia severity.
Airway and Lung Alveolar Epithelia
As indicated above, the ASL is produced by subjacent airway and lung epithelial layer that is
specialized along the respiratory tract. The inner nares is lined by stratified squamous
epithelium that transitions into pseudostratified ciliated epithelium that lines the nasal meatus
and conchae (turbinates). Intervening within the pseudostratified ciliated epithelium are goblet
cells that release mucin products discussed above and also submucosal glands. In the ethmoid
region, additional nerve sensory fibers enter the respiratory epithelia and mediate olfactory
sensations. Pseudostratified ciliated epithelia, along with submucosal glands, line the frontal
and ethmoid sinuses, trachea and bronchi. Lung bronchioles mucosa has a thinner epithelial
layer (one cell layer thick) lined by both type II and Clara cells (Fig 1). Both cell types produce
surfactant and surfactant proteins and can serve as progenitors cells; type II cells are progenitors
for other type II cells and type I cells that line lung aveoli. Clara cells produce daughter cells
that can be Clara cells or type II cells. Clara cells also express mixed function oxidases
(cytochrome p450 isoenzymes such as CYP1A1 and CYP1A2) that detoxify inhaled toxins
and/or toxins that are spread hematogenously. This is a beneficial feature for some toxins;
however, for others, such as 3-methyl indole (3 MI), a toxic metabolite, 3-methylindololamine
is formed that causes Clara and airway epithelial cell injury and necrosis. With loss of these
cells, there is concomitant loss of the epithelial barrier and the overlying air-surface liquid
containing antimicrobial factors. 3 MI is present in certain feedstuffs such as foggage, rape,
and kale. Clara cells also produce Clara cell secretory protein 10 (CC10). CC10 is an important,
yet subtle, immunomodulator of lung physiology, influencing synthesis, secretion, and
function of molecules such as phospholipase A2, interferon gamma, and locally produced IgA.
Generally, it is an immunosuppressive and antiflammatory protein that is important in limiting
the collateral damage caused by inflammatory cells such as neutrophils.
Ackermann et al. Page 4













Microbial pattern recognition molecules
Epithelial cells are central to respiratory systems sensing of the external environment. Most
particulate matter and microbial agents are removed from the inhaled air in the nares, nasal
conchae and trachea leaving the deeper lung sterile and relatively free from particulate material.
These substances, along with mists, vapors, and gases once through the ASL can bind the lung
epithelia and trigger activation, cell injury, metaplasia, or cell death. Microbial agents produce
a number of conserved molecular patterns, termed pathogen associated molecular patterns
(PAMPs) that include substances such as teichoic acid from Gram-positive bacteria,
lipopolysaccharide (LPS) from Gram-negative bacteria, cytokine-phosphate-guanine (CpG)
DNA, single-and double-stranded RNA (dsRNA), flaggelin, fungal zymosan, and lipopeptides
from mycobacteria. Major pathogens of cattle: Histophilus somni, Mannhemia haemolytica,
Pasteurella multocida, Mycoplasma bovis, bovine herpesvirus-1 (BHV-1; infectious bovine
rhinotracheitis), parainfluenza virus, bovine respiratory syncytial virus, bovine viral diarrhea
virus (BVD), all produce some type of PAMP that are recognized by epithelia, alveolar
macrophages, and intravascular macrophages. Intravascular macrophages are macrophages
within the small capillaries of alveolar walls, attached to the underlying endothelial cells that
are very active in metabolic generation of inflammatory mediator such as prostaglandins and
leukotrienes. With acute inflammation, neutrophils also recognize PAMPs, and with adaptive
immune responses, the various lung dendritic cells (DCs), including plasmcytoid DCs, NK
cells, NK T cells, alpha/beta and gamma/delta T cells and B cells all interact with microbial
PAMPs.
The lung, like other organs, expresses a wide variety of extracellular, cell surface, endosomal
and cytoplasmic receptors that recognize microbial PAMPs, termed pattern recognition
receptors (PRR). Extracellular PRR include LPS binding protein, mannan-binding lectins such
as ficolin and collectins, and also C-reactive protein and serum amyloid protein. In swine,
single nucleotide polymorphisms (SNP) in these mannan-binding lectin C are associated with
increased respiratory disease (10).
Cell surface PRR on respiratory epithelia include Toll-like receptors (TLR), which are
transmembrane receptors that have outer leucine-rich repeats (LRR) and cytoplasmic Tll/
interleukin-1 (IL-1) receptor homology domains that transmit signals to the nucleus once the
outer LRR are activated by PAMPs. The TLR activate NF-kappaB or the interferon regulatory
factors 3 and 7 (IRF 3, 7). Cattle have ten TLR that have specific and sometimes overlapping
PAMP affinities. In short, TLR 1 has affinity for tri acyl lipopeptide of mycobacteria, TLR2
has affinity for peptidoglycans of Gram-positive organisms and lipoarbinomannan of
mycobacteria, zymosan of fungi, TLR 3 has affinity for ds RNA, TLR 4 has affinity for LPS,
TLR 5 has affinity for flagellin, TLR 6 has affinity for diacyl lipopeptides of mycoplasma,
TLR 7 and 8 has affinity for ss RNA, TLR 9 has affinity for CpG and TLR 10 is not yet fully
assessed. As indicated, several TLR (1,2,5,6–9) signal through MyD88 which leads to NF
kappa B activity and inflammatory reactions whereas other TLR (3) are MyD88 independent
(signaling through TRIF/TRAF) and induce IRF 3, 7 and type I interferon genes. TLR 4 can
signal through MyD88 or TRIF/TRAF, depending upon the stimulus. LPS, a bacterial
component of Histophilus somni, Mannhemia haemolytica, and Pasteurella multocida, first
binds LPS binding protein, soluble CD14 and the TLR4 cofactor MD2 before fully activated
TLR4. TLR 4 is also bound by the F protein of RSV.
Bovine respiratory viruses, BHV-1, PI-3, RSV and BVD, can infect lung epithelial cells.
Viruses can induce formation of non-capped, 5′triphosphated RNA, long ds RNA, ssRNA,
viral DNA, along with their capsids, matrix proteins, and non-structural proteins. These signal
through TLR 3, 7, 8 and 9 as indicated above but recent work has also characterized cytosolic
viral pathogen recognition receptors, retinoic acid induced gene-I (RIG-I) and melanoma
differentiation associated gene-5 (MDA-5). These proteins have an RNA helicase and caspase
Ackermann et al. Page 5













recruitment (CARD) structural domains and recognize noncapped 5′ triphosphated RNAs
(RIG-I) and ds RNA (MDA-5). RIG-I and MDA-5 activate NF-kappaB and IRF-3 and -7 via
mitochondrial antiviral signaling adaptor (MAVS), interferon-beta promoter stimulator
(IPS-1), virus-inducing signaling adaptor, and Cardif.
Other cytosol receptors include the nucleotide binding domain, leucine—rich repeat (NOD)-
like receptors which can detect viral, bacterial, and other pathogens that enter the cytoplasm.
Over 20 NOD-like receptors have been identified. NOD 1 and 2 binding peptidoglycan, IPAF
recognizes flagellin, and NALP3 recognizes a very broad range of exogenous and endogenous
molecules including viruses, low intracellular potassium, toxins, ultraviolet light, asbestos,
silica aluminum, and urate crystals. NOD-like receptors have leucine rich-repeat domains that
recognize pathogens. The NOD-like receptors stimulate cell activation. In macrophages,
NALP3, IPAF, and NALP1 are components of the inflammasome. The inflammasomes induce
activity by triggering caspase 1 activation that results in cleavage of pro-interleukin 1 beta
(IL-1 beta) to active IL-1 beta and active IL-18. IL-1 beta and IL-18 bind their respective
receptors on leukocytes and other cells which triggers pro-inflammatory responses.
While NF-kappa beta and IRF-3 or -7 can be activated by TLR, RIG-I, MDA-5, and NOD-like
proteins, endogenous molecules such as heat shock proteins 60 and 70, urates, adenosine, and
other molecules can also activate epithelial cells, macrophages and other inflammatory cell
types in the lung. These are term danger-associated molecular patterns (DAMPs) or alarmins.
While DAMPs activate these inflammation transcription factors, their activation signal is
modulated by simultaneous binding to CD24 which interacts with Siglec which reduces the
intensity of NFkappa B activation.
Oxidative killing by respiratory epithelia
More recently, an oxidative defense system (ODS) has been identified in human and ovine
respiratory tract. Because it is active in ovine, it is likely also present in cattle. The ODS requires
activity of epithelial enzymes dual oxidases1 and 2 (Duox1 and Duox2) which are members
of the NADPH oxidase family and generate hydrogen peroxide production onto the ASL. In
the presence of thiocyante (SCN-), the hydrogen peroxide which is weakly microbicidal is then
converted to a more toxic compound, hypothiocyanite (OSCN-), which is short-lived but highly
microbicidal.
Cytokines, chemokines, interferons
Acute inflammatory cytokines such as interleukin-1 (IL-1), tumor necrosis factor (TNF), and
interleukin 6 (IL-6) invoke activation of nearby cells including endothelial cells, epithelial
cells, alveolar macrophages and lung dendritic cells. With activation there release of
chemokines that attract migration of neutrophils and monocytes into the affected area and with
time also attract DCs, NK, T and B cells. Inflammatory chemokines include IL-8 (CXCL8),
GCP-2 (CXCL6), ENA-78(CXCL5), Gro(CXCL1-3), IP-10 (CXCL10), I-Tac (CXCL11),
RANTES (CCL5), MIP-alpha (CCL3) and beta (CCL4), MCP 1–5 (CCL7, 8, 12, 13) and
eotaxins 1–3 (CCL24, 26) depending upon the stimulus with receptors that include CXCR1,
2, 3 and CCR1, 2, 3, and 5. Lymphocytes that home to the lung use a different set of chemokines
(e.g. naïve cells express CCR1-10, CSCR1-3 and memory cells express CCR8-10, CSCR1, 2,
4, 5). Chemerin is a chemotactic factor for DCs and macropahges through binding of
chemokine-like receptor 1 (CMKLR1).
Some viral infections activate viral receptors that invoke IRF-3 and -7 which stimulate
production of type I interferons (IFN alpha and beta) that are released by numerous cells types.
These interferons bind Jak/Stat receptors of adjacent cells to induce expression of anti-viral
substances that include: the ISGlyation pathway which complexes with IRF-3 and prevents
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degradation, MxA protein which binds and traps viruses, 2′,5′-oligoadenylate synthetase 1
(OAS1) activates RNaseL which cleaves viral RNA, Protein kinase R (PKR) which dimerizes
in the presences of viral RNA and inhibits eukaryotic translation initiation factor 2 alpha (EIF2
alpha) to reduce viral replication.
Effector cells
In addition to respiratory epithelia, major innate immune effector cells include the vascular
endothelium, neutrophils, alveolar and intravascular macrophages, dendritic cells, NK cells,
NK T cells, eosinophils and mast cells. With acute inflammatory responses, endothelial cells
become activated by inflammatory mediators, open gaps, and allow passage of serum factors
into the lung; especially alveolar lumens. This fluid contains dilute microbial agents and toxins
physically, and contain numerous molecules with protective immune function such as
complement, hydrolytic enzymes, IgG, IgM, IgA, IgE, collectins, acute phase proteins, and
others. Endothelial cells also release inflammatory mediators and express adhesion molecules
that mediate passage of leukocytes into sites of infection/injury. Neutrophils internalize
microbial agents, foreign substances, and other particulates, release their granule contents, and
upon death release neutrophil extracellular traps (NETs) composed of DNA, histones, and
antimicrobial peptides (alpha defensins) that entrap microbes. NK cells do not require previous
antigenic exposure to kill virus-infected cells. They express CD161 and CD56 and are activated
by interferon and macrophage cytokines to produce interferon gamma and release perforin to
kill virus-infected cells. In many species, activation of macrophages occurs in a classical, pro-
inflammatory/cell-mediated Th1-type response induced by interferon gamma and TNF; an
alternative Th2-type response induced by IL-4, and an anti-inflammatory, regulatory response
induced by IL-10. In cattle; however, the Th1/Th2 paradiagm is not as clearly distinct,
functionally, as in other species. Despite this, alveolar and intravascular macrophages of the
bovine do function in generation of cell mediated, humoral, and regulatory (inhibitory)
responses. In allergic (Th2-type) conditions, eosinophilic and mast cell infiltration occurs with
release of granule content. Once established, inhaled antigen can cross-link IgE receptors on
mast cells and basophils resulting in cellular activation.
Factors that can alter respiratory immunity
The bovine lung has anatomical features which predispose cattle to respiratory infections. This
is reviewed elsewhere (4). Briefly, cattle have a relatively increased area of dead space, as
indicated, and they also have a right tracheal bronchus. The bovine lung has interlobular septae
with limited interdependence, increased resistance and decreased compliance; and collateral
ventilation is reduced due to a lack of: a) broncho-alveolar communication (channels of
Lambert), b) alveolar pores (pores of Kohn) and c) interbronchiolar connections (channels of
Martin). Due to the lack of collateral ventilation, atelectasis occurs readily and these areas of
lung remain consolidated and lack functional gaseous exchange. Regions of atelectasis are also
under hypoxic vasoconstriction whereby arterioles shunt blood flow away from these areas to
better perfuse regions with adequate gaseous exchange. Thus, these anatomic and physiologic
conditions increase the demands for protective immune responses.
There are several environmental factors and managerial issues that also can lower the
respiratory tracts immunity. These include transportation, weaning, overcrowding, changes in
social structure, precipitation, fluctuations in temperature, humidity, air exchange, lighting,
sounds, changes in feedstuffs, feedlot floor conditions, and other microbial agents. These can
affect even basic aspects of the immune system. For example, although corticosteroids
(dexamethasone), catecholamines, acetylcholine, and substance P do not affect basal level of
TAP and LAP expression by respiratory epithelial cells, dexamethasone exposure reduces TAP
and LAP expression upon exposure to LPS (11). In addition, infection with type 2 bovine viral
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diarrhea virus (BVDV) also reduces LPS-induced expression of TAP (and lactoferrin) but a
type 1 non-cytopathic BVD strain had no effect (12).
Other conditions that impair immune responses may include single nucleotide polymorphisms
within genes encoding innate and adaptive immune responses of the lung as studied in swine;
however, no large scale studies have been completed in cattle, to date.
Diagnostic biomarkers
Some innate immune molecules have use or potential use is assessing respiratory tract function/
activity or stage/severity of clinical disease. Surfactant protein A (SP-A) production by lung
epithelia increases markedly in fetal lung near term and thus roughly delineates the level of
lung maturation at birth. SP-A production can also be increased with viral pneumonia and enter
the pulmonary lymphatic vessels where it is carried by the thoracic duct to the systemic blood
circulation. Thus, serum SP-A measurement has potential to be a marker of respiratory tract
maturation and also pneumonia severity.
Recent work has shown that acute phase proteins are clinical markers of pneumonia severity.
Serum associated amyloid (SAA), haptoglobin, alpha 1-acid glycoprotein produced by liver
in response to IL-1 and TNF alpha are produced during pneumonia. SAA and haptoglobin can
differentiate acute and chronic pneumonia and alterations in haptoglobin and apolipoprotein
A1 are associated with viral infections (13). Metabolic and elemental compounds are
biomarkers of viral infection (glucose, low density lipoprotein (LDL), valine, phosphorus, and
iron) and disease outcome (lactate, glucose, iron) (13).
RECENT DEVELOPMENTS IN ADAPTIVE IMMUNE RESPONSES
Several excellent reviews of respiratory adaptive immune responses to bovine pathogens have
detailed advanced concepts in cellular and molecular immunology in this text series (14) and
other journals (15,16). These pathogens can evade respiratory immune responses by
modulating: 1) the host immune response, and/or 2) the microbial phenotype or location (15).
In addition, it is commonplace for investigators to study neutrophils, alveolar macrophages,
and other airway cells retrieved by bronchoalveolar lavage. In contrast, few investigative
studies have examined the precise role of adaptive immune cells (dendritic, gamma/delta T,
alpha/beta T, B, NK, and NK-T cells) in the respiratory mucosa, bronchus-associated lymphoid
tissue (BALT), and tracheobronchial lymph nodes. Such studies could be completed with laser
capture microdissection coupled with flow cytometric analysis and microarray. Moreover, the
dynamic interaction between these cells and their migration to and from the tracheobronchial
lymph node have not been fully assessed. Clearly, there is antigen exposure in the lung airways
that triggers differentiation, maturation, and responses by these cells that have a kinetic
progression with time. The progression and cellular/molecular responses are likely very
different in neonatal lung upon initial encounter to a newly inhaled antigen and repeated
exposure of an antigen in an older animal. This dynamic is further complicated by vaccination.
Passive transfer (colostrum)
Adaptive responses of the bovine neonate including failure of passive transfer (FPT) have been
reviewed (17,18). With FPT there are inadequate levels of maternal IgG, particularly IgG1
which comprises 80% of IgG) and other immunoglobulins that increase risk of respiratory
infection. More recently, additional components of colostrum appear to influence the
development and activity of the neonatal calf immune system. Maternal colostral leukocytes
reduce CD11a+ lymphocytes in neonatal calf blood and these calves have higher CD25, CD26,
and MHC I expressing lymphocytes. Thus, maternal colostral leukocytes accelerate fetal
lymphocyte development (19).
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Pro-inflammatory cytokines are also present in colostrum. IL-beta, IL-6, TNF alpha, and IFN
gamma are significantly increased in colostrum but reduced to zero or nearly zero by day 5 of
lactation. The high colostral levels of these cytokines correspond to increased levels in the
serum of neonatal calves (20). Serum cytokine levels of IL-1 beta, IL-1 alpha, TNF alpha, IL-6,
and IFN gamma, peak at day 12–24 hours after birth and progressively decrease to zero or near
zero by day 21. One study has shown also shown high levels of IL-18 in colostrums and
increased serum levels of IL-18 in neonates by 6 hours post colostral ingestion (21). The
increased colostral cytokines appear to trigger neutrophils function since colostral whey
enhances neutrophil functional assays(cytochrome C reduction and iodination) (22). This
findings suggesting that the colostral cytokines are important for neutrophil “readiness” in
newborn animals. This likely has a systemic protective effect since neutrophil function is vital
for the protection of respiratory airways, intestine, and other mucosal surfaces against microbial
pathogens.
Gamma/delta T cells
The generation of humoral and cellular responses of the adaptive immune system by the bovine
are described by Srikumara and Goldsby (15,23). These occur simultaneously with innate
immune responses. The adaptive responses are contingent upon antigen recognition, antigen
processing and presentation by dendritic cells, and involvement of gamma/delta T cells and
alpha/beta (CD 4 and CD8) cells. Of these, gamma/delta T cells of cattle are of special interest
for at least two reasons. First, newborn calves have an unusually high number of circulating
gamma/delta T cells and secondly, gamma/delta T cells of ruminants express WC-1 antigen.
Gamma/delta T cells account for 60% of the peripheral blood mononuclear cells in young
calves. WC1+ gamma/delta T cells are considered an inflammatory population whereas CD1-
gamma/delta T cells are regulatory with myeloid cell features. Within the WC1+ phenotype
are WC1.1+ and WC1.2+ subsets that differ in their interferon gamma (IFN gamma) production
and proliferative responses to stimuli (24,25). The role of WC protein is not fully understood
but it may be a homologue of CD4 and CD8 antigens on alpha/beta T cells by regulating
gamma/delta T cell responses or transmission of signals from the outside into the cell (26). It
is possible that WC protein binds microbial PAMPs similar to other proteins with similarities
to WC.
CLINICAL IMPLICATIONS
A 2009 study of bovine respiratory disease (BRD) in an Oklahoma feedlot underscores the
complexity of this disease and its clinical impact (27). BRD morbidity was 14.7% in that herd
with 0.7% mortality. The mean fatal disease onset was 32.6 days and mean treatment interval
was 29 days, mean number of antibiotic treatments were 2.6 days, and mean day of death 61.8
days. All of the agents listed at the beginning of this chapter were isolated from the cattle.
These agents were correlated with mortality, treatment, lesion and association with other
agents. Also correlated were the type of lesions with mortality, treatment and infectious agent.
Interestingly, along with bovine viral diarrhea virus (BVDV)-1a and 2b, BVDV-1b was
identified in fatal cases and this was considered noteworthy because most current BVDV
vaccines contain BVDV-1a and 2b but not BVDV1b The work also identified BVDV-2b for
the first time. This study confirms the continued presence of and damage caused by these
microbial agents in 2009. Thus, despite advancements in managerial practices, vaccine
development, antimicrobial agents, medicine, and molecular diagnostics, BRD each of these
agents remain to be a significant concern.
The innate immune response can be viewed as the basal, most basic immune response to
pathogen but it is a response that is difficult to enhance therapeutically. As with adaptive
immune responses, there is redundancy and overlap in the function of innate immune products
that protect the respiratory tract. However, loss of some innate factors is clearly associated with
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increased incidence and/or severity of respiratory disease. Factors that influence this include:
dehydration, genetic changes resulting in altered expression of innate immune factors, stress,
and primary infection.
Dehydration
It is well known that dehydration causes increased viscosity of the respiratory secretions. The
sol layer of the respiratory air-surface liquid is reduced resulting in increased mucinous material
which can allow increased colonization of bacterial pathogens and accumulation of inhaled
particulate matter due to reduced mucociliary function.
Genetic changes resulting in altered expression of innate immune factors
Single nucleotide polymorphisms (SNPs) are single nucleotide changes in a particular animal
that can result in production of a different amino acid in a protein. Although this is a very slight
change, a single amino acid change may greatly change the function of an innate immune
factor. As indicated, studies in pigs have demonstrated that SNPs in mannan-binding lectin C
are associated with increased susceptibility to respiratory disease. Humans with SNPs in
surfactant protein A and D have increased incidence and severity of respiratory syncytial virus
pneumonia. Identifying an association between SNPs and increased respiratory disease often
requires large-scale genetic studies matched to clinical disease scores and thus are often
expensive. However, SNPs within a cattle herd that has minimal genetic variation could have
profound effects.
Stress
Causes of stress are varied but include overcrowding, lack of shade in the hot summer, rapid
and extreme fluctuations in temperature, wind, shipping, persistent startling (e.g., dogs,
coyotes, traffic noise) and other situations that change the physical and/or mental homeostasis
of cattle. Stress affects cortisol levels, among other endogenous stress responses, and
corticosteroids (dexamethasone) can reduce innate immune expression of defensin genes in
response to LPS, as indicated. Thus, there appears to be a direct effect of stress on certain innate
immune factors.
Primary infection
As indicated, all animals have a commensal microflora in the upper respiratory tract and
nasopharynx. Changes in these secondary to stress, dehydration or SNPs, can allow increased
proliferation of pathogens. For example, stressed cattle can have increased proliferation of
Mannheimia haemolytica in the nasopharynx and tonsil. In addition, with reduced innate
immune responses organisms such as Mycoplasma bovis, and viruses (PI-3, RSV, BVDv) have
enhanced opportunities to colonize, proliferate and damage the respiratory epithelia setting the
stage for secondary bacterial pathogens with increased virulence.
Reducing the effects and duration of these factors are a first step in enhancing innate immune
activity. With time, therapies aimed toward enhancing activity of some innate immune
responses may become a viable option and adjunct to management, vaccination, and
antimicrobial agents.
SUMMARY
The bovine respiratory tract immune response is sophisticated and shaped by anatomic and
cellular features unique to cattle/ruminants, management practices, and interactions with
specific microbial pathogens. Because extensive inflammatory reactions impair gaseous
exchange and lung function, innate immune responses are vital for sensing and handling
pulmonary exposures to particulates, vapors, microbial agents and other inhaled substances
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without invoking a marked inflammatory reaction. Cattle have anatomic features such as
reduced collateral ventilation that reduce the effectiveness of the innate immune response and
current managerial practices sometimes weaken the innate immune response. With persistence
or repeated exposure to antigens or insults, adaptive immune responses are generated. Neonatal
calves require colostrum for fully functional adaptive responses and have high levels gamma/
delta cells that contribute significantly to adaptive responses in concert with dendritic cells,
NK cells, macrophages, alpha/beta T cells, and B cells.
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Schematic illustration of the bovine respiratory immune system emphasizing the innate
components. Depicted are immune systems within three main regions of the respiratory tract:
the airways (upper respiratory tract to the bronchi), bronchiole, and alveoli. Airway.
Conducting airways are lined by pseudostratified ciliated epithelium that transports the air-
surface liquid (ASL) anteriorly toward the pharynx or nares. ASL is produced by secretion
products from goblet cells and submucosal glands. Within the ASL are mucins (see text) as
well as antimicrobial proteins (e.g., lysozyme, lactoferrin, surfactant proteins A and D, SLPI,
PLUNC and others); and antimicrobial peptides (defensins and RNAase 7) which are produced
by ciliated epithelial cells. The oxidative defense system (ODS) is composed of lactoperoxidase
(LPO) produced by submucosal glands, dual function oxidases 1 and 2 (Duox1 and Duox2)
produced by epithelia, and thiocyanate (SCN-) transport proteins produced by epithelia. Duox1
and 2 produce hydrogen peroxide (H2O2) which, in the presence of SCN-, is converted to
OSCN-, which has potent antimicrobial activity. Bronchioles. Bronchioles are lined by Clara
and Type II cells both of which also produce antimicrobial proteins and peptides. Clara cells
also produce CC10, an immunomodulatory protein, and express cytochrome P450 enzymes
that biometabolize toxins. With injury, Type II and Clara cells proliferate and replace damage
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cells. Airways. Type I pneumocytes line the alveolar lumen and are covered by surfactant
phospholipids that are admixed with surfactant proteins, antimicrobial proteins, and
antimicrobial peptides. With injury Type I pneumocytes are replaced by Type II cells which
then differentiate into Type I cells. Effector cells. Neutrophils, alveolar and intravascular
macrophages, alpha/beta T (CD4 and CD8) cells and gamma/delta T cells along with B, NK,
and dendritic cells are effector cells present along the respiratory tree for induction of adaptive
immune responses. With inflammation, neutrophils and macrophages are present in the
alveolar lumen, bronchioles and airways. Other immune responses such as pattern recognition
receptors as well as cytokine, interferon, and chemokine responses are not included in this
figure.
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